Possibility of decrease in CYP1A2 function in patients with end-stage renal disease.

Abstract

Propranolol, the substrate of cytochrome P450 (CYP) 1A2 and CYP2D6, has been reported to be in high concentrations in end-stage renal disease (ESRD) patients. This has been thought to be due to the decrease in the nonrenal clearance of propranolol. The objective of this study is to elucidate the reason for the decrease in nonrenal clearance in ESRD patients… (More)
DOI: 10.1111/1744-9987.12100

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.